Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

investors.com/news/technology/sanofi-vigil-neuroscience-acquisition/?src=A00220

Dollar stock Vigil Neuroscience (VIGL) tripled Thursday after French drugmaker Sanofi (SNY) agreed to buy it for $470 million plus a contingent value right tied to its experimental Alzheimer's treatment.
"The timing of the acquisition bid represents a best-case scenario for VIGL,"…

This story appeared on investors.com, 2025-05-22 14:06:05.
The Entire Business World on a Single Page. Free to Use →